Now that researchers have had a chance to survey the entire human genome, they believe that, contrary to previous predictions of 100,000 or more, it contains just 35,000 to 45,000 genes. That means a sizable percentage of the total could already be covered by gene patents. But the shrinking gene count could be a mixed blessing for companies and others, from universities to governments, that have rushed to lay claim to gene uses.